Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MMP inhibitors from Pfizer reportedly useful for inflammatory disorders and cancer

Jan. 22, 2001

Two new clinical trials commence with Genasense for leukemia

Jan. 22, 2001

FDA denies approval of Aronex's Atragen for APL

Jan. 22, 2001

Antitumor compounds active against solid tumors and leukemias in the ADIR pipeline

Jan. 19, 2001

Halofuginone affects critical steps in the angiogenic process

Jan. 19, 2001

Worldwide licensing arrangement announced for TZT-1027

Jan. 19, 2001

Aphton to commence study of GnRH pharmaccine in combination with Taxotere

Jan. 19, 2001

Study of RSR-13 in combination with chemotherapy commences

Jan. 19, 2001

Bioniche's MCC technology approved for prostate cancer clinical trials

Jan. 19, 2001

Japanese patent covers new antitumor compounds designed by Kyowa Hakko

Jan. 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...